Evommune, Inc.

The market value of the company, based on the listing results, was estimated at more than $480 billion

Evommune IPO: shares in atopic dermatitis treatment developer become available

Novo Nordisk A/S

Pfizer Inc.

Novo Nordisk, the maker of obesity drugs Wegovy and Ozempic, and US pharma company Pfizer have improved their offers to buy US startup Metsera, which develops weight-loss drugs. The company itself still considers Novo's offer "more favorable" despite the escalating battle for the deal, the Financial Times <a href="https://www.ft.com/content/ab202cb5-ee27-4257-b2ee-431408c970c1">writes</a>.

Novo Nordisk and Pfizer raise stakes in battle for weight loss drug developer

Abbott Laboratories

Air Products and Chemicals, Inc.

Johnson & Johnson

Generac Holdings Inc.

ITT Inc.

Marex Group plc

Amazon.com, Inc.

GitLab Inc.

NVR, Inc.

Barrick Mining Corporation

Anglo American plc

Sibanye Stillwater Limited

AI is a risky strategy, real production is a conservative one: Oninvest asked Astero Falcon portfolio manager Alena Nikolaeva where to invest $10,000 if the horizon is about a year and the goal is to increase capital. Two strategies include companies from the "old" economy.

Where to invest $10,000 right now: the renaissance of real manufacturing 

Regeneron Pharmaceuticals, Inc.

The 2025 Nobel Prize in Physiology or Medicine <a href="https://www.nobelprize.org/prizes/medicine/2025/press-release/">was awarded to</a> Mary E. Bruncoe, Fred Ramsdell and Shimon Sakaguchi for discoveries in the workings of the immune system that pave the way for treatments for autoimmune diseases and cancer, as well as easier organ transplantation. The mechanism they discovered is called peripheral immune tolerance - sounds confusing, let's figure it out.

Rabbits vs. scientific dogma: what you need to know about the Nobel Prize in Medicine

The fact that artificial intelligence is used in almost all spheres of human life is no surprise to anyone. But the case of Albania, where the first virtual minister appeared in September this year and was allowed to distribute public finances, raises many important questions. Among them is how actively AI should be involved in government management and how it should be controlled. Vadim Novikov, Advisor to the President of Almaty Management University (AlmaU), discusses this.

The Altar of Power and the Machine: Will Artificial Intelligence Replace the State?

Cronos Group Inc.

Canopy Growth Corporation

Tilray Brands, Inc.

An exchange-traded fund tracking the industry has fallen 90% in price since the peak of investment in marijuana growers

Trump released a video about marijuana products. Producers' stocks went up

Ionis Pharmaceuticals, Inc.

Quotes of biotech Ionis Pharmaceuticals jumped 35% in a single day after it announced a successful trial of a drug that reduces triglyceride levels in the blood and prevents cases of acute pancreatitis. Analysts were positive about the results. The company, which is known for its Spinraza drug for spinal muscular atrophy, could see its shares rise another 40%, according to some analysts' models.&nbsp;

Biotech Ionis Pharmaceuticals surges 35% after upbeat trial of triglyceride drug

Shoulder Innovations, Inc.

Shares of Shoulder Innovations, a small-cap maker of shoulder implants, <a href="https://finance.yahoo.com/quote/SI/">surged</a>&nbsp;more than 18% yesterday, August 25, after at least four Wall Street analysts <a href="https://www.cnbc.com/2025/08/25/goldman-says-this-specialized-medical-implant-stock-has-more-than-50percent-upside.html">initiated </a>coverage with bullish calls. Goldman Sachs, for example, set a target price that implies upside of more than a third.

Four banks initiate coverage with 'buy' call on Shoulder Innovations; shares soar

Tesla, Inc.

Meta Platforms, Inc.

In mid-August, it became known that OpenAI CEO Sam Altman intends to <a href="https://www.ft.com/content/04484164-724e-4fc2-92a2-e2c13ea639bd">back</a> Merge Labs, a company that is developing a brain-computer interface - a class of technology that allows people to control computers using neural signals from the brain, i.e., actually by the power of thought. This further intensifies competition with his former partner and now rival Elon Musk, who launched a similar startup, Neuralink, in 2016. So far, the technology is being used with the noble goal of helping completely paralyzed people to communicate with the world around them again by controlling computer interfaces. However, both billionaires believe that in the long run, this technology will literally save humanity from extinction.

The great merger: why billionaires are getting in our heads

Heartflow, Inc.

The company raised $316.7 million, more than it had expected

Medtech Heartflow IPOs, shares now available for Freedom clients

Shares of Shoulder Innovations, a medical company that develops implants for shoulder surgeries, became available July 31 on the Freedom client trading system. The securities are listed under the ticker <a href="https://tap.freedom24.com/to/quote/SI.US?utm_source=stocks&amp;utm_medium=SI.US&amp;utm_campaign=pfu8656964">SI</a>. They will appear on the New York Stock Exchange in a few hours.&nbsp;

Shoulder Innovations IPO: shares of medtech with AI solutions for surgery become available


Pheton Holdings Ltd

Chinese micro-cap company Pheton Holdings, whose shares trade on the Nasdaq, <a href="https://finance.yahoo.com/quote/PTHL/">crashed</a> and lost nearly 95% of its value yesterday, July 29. Investors were reacting to a <a href="https://thebearcave.substack.com/p/problems-at-pheton-holdings-pthl">report</a> by the Bear Cave, a newsletter that "exposes corporate misconduct," which alleged that Pheton is "being manipulated by overseas stock manipulation groups and is at risk of a near-term, severe stock collapse" and called on regulators to halt trading in the stock before U.S. investors lost millions.